Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChinaQ: QoL in PD vs HD
NCT02378350Phase 4Completed
- Sponsor
- Vanttive
- Start
- Mar 2014
- Primary completion
- Sep 2017
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of peritoneal dialysate in end stage renal disease (ESRD) (2 arms), sponsored by Vanttive. Primary endpoint: Kidney Disease Quality of Life-Short Form (KDQoL-SF) Burden of Kidney Disease Domain at 1 year. Started Mar 2014; status: completed.
02
Drugs
peritoneal dialysate
03
Conditions
end stage renal disease (ESRD)
Beyond the preview
Go deeper on NCT02378350.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02378350.